Aravive Inc (NASDAQ:ARAV)
| 2.30 Delayed Data As of Mar 24 |  +0.03 / +1.32%Today’s Change | 0.58 Today|||52-Week Range 2.46 | +74.24% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $116.1M |
Company Description
Aravive, Inc. operates as a clinical stage biotechnology company, which engages in the development of transformative treatments designed to halt the progression of life threatening disease, including cancer and fibrosis. The company was founded on December 10, 2008 and is headquartered in Houston, TX.
Contact Information
Aravive, Inc. River Oaks Tower Houston Texas 77098 |
Employees
Shareholders
| Individual stakeholders | 51.15% |
| Other institutional | 10.80% |
| Mutual fund holders | 1.49% |
Top Executives
| Gail Frances McIntyre | President, Chief Executive Officer & Director |
| Leonard Scott Dove | Chief Operating Officer |
| Rudy C. Howard | Chief Financial & Accounting Officer |
| Robert B. Geller | Chief Medical Officer |
| Marek Ciszewski | Vice President-Investor Relations |
